Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 1 EUR 1.01% Market Closed
Market Cap: 53.4m EUR

Intrinsic Value

SEQUA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SEQUA stock under the Base Case scenario is 0.01 EUR. Compared to the current market price of 1 EUR, Sequana Medical NV is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SEQUA Intrinsic Value
0.01 EUR
Overvaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sequana Medical NV

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
SEQUA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SEQUA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Sequana Medical NV
XBRU:SEQUA
BE
Health Care
Market Cap
53.4m EUR
IPO
Feb 11, 2019
BE
Health Care
Market Cap
53.4m EUR
IPO
Feb 11, 2019
Price
€false
EPS
€false
AI Assistant
AI Assistant
Ask me anything about Sequana Medical NV
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sequana Medical NV

Current Assets 6.4m
Cash & Short-Term Investments 3.8m
Receivables 563k
Other Current Assets 2m
Non-Current Assets 3.5m
Long-Term Investments 104k
PP&E 3.4m
Efficiency

Free Cash Flow Analysis
Sequana Medical NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sequana Medical NV

Revenue
106k EUR
Cost of Revenue
-3.3m EUR
Gross Profit
-3.2m EUR
Operating Expenses
-15m EUR
Operating Income
-18.2m EUR
Other Expenses
-26.4m EUR
Net Income
-44.7m EUR
Fundamental Scores

SEQUA Profitability Score
Profitability Due Diligence

Sequana Medical NV's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
ROIC is Increasing
Negative 1-Year Revenue Growth
28/100
Profitability
Score

Sequana Medical NV's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

SEQUA Solvency Score
Solvency Due Diligence

Sequana Medical NV's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
29/100
Solvency
Score

Sequana Medical NV's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SEQUA Price Targets Summary
Sequana Medical NV

Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.05 EUR with a low forecast of 2.93 EUR and a high forecast of 5.25 EUR.

Lowest
Price Target
2.93 EUR
193% Upside
Average
Price Target
4.05 EUR
305% Upside
Highest
Price Target
5.25 EUR
425% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sequana Medical NV
does not pay dividends
Shareholder Yield

Current shareholder yield for SEQUA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SEQUA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SEQUA stock?

The intrinsic value of one SEQUA stock under the Base Case scenario is 0.01 EUR.

Is SEQUA stock undervalued or overvalued?

Compared to the current market price of 1 EUR, Sequana Medical NV is Overvalued by 99%.

Back to Top